https://www.indianpharmapost.com/syngene-q1-fy27-revenue-declines-16-to-rs-736-crore-sharpens-focus-on-cdmo-and-ai-led-growth-211442026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/gland-pharma-receives-usfda-approval-for-generic-sugammadex-injection-211452026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-receives-anvisa-nod-for-semaglutide-injection-in-brazil-211462026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/rpg-life-sciences-revenue-rises-to-rs-1957-crore-in-q1-fy27-211472026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/dabur-india-q1-fy27-net-profit-jumps-15-to-rs-591-crore-211482026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/cupid-increases-investment-in-gii-healthcare-to-strengthen-strategic-partnership-211492026-07-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-medical-device-2026-to-spotlight-innovation-self-reliance-and-global-competitiveness-211502026-07-30T00:00:00+05:30always0.9